CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Revenue	$ 310,125		$ 310,125
Cost of revenue	200,294		200,294
Gross profit	109,831		109,831
Operating expenses:
Research and development	289,413	288,601	669,699	500,280
General and administrative	652,754	514,387	1,200,400	1,061,498
Sales and marketing	132,056	158,556	240,751	254,455
Total operating expenses	1,074,223	961,544	2,110,850	1,816,233
Loss from operations	(964,392)	(961,544)	(2,001,018)	(1,816,233)
Other expense (income)
Interest expense	116,309		154,336
Change in fair value of derivative and warrant liabilities	2,889,557		4,471,963
Amortization of derivative and warrant liability discount	1,094,437		1,445,862
Amortization of deferred debt issuance costs and original issue discount	461,289		604,861
Other expense, net	1,924	(2,479)	1,868	2,311
Nonoperating Income (Expense)	4,563,516	(2,479)	6,678,890	2,311
Net (Loss)	$ (5,527,908)	$ (959,065)	$ (8,679,909)	$ (1,813,922)
Basic and diluted net (loss) per share	$ (0.05)	$ (0.01)	$ (0.08)	$ (0.02)
Weighted average common shares outstanding	108,041,084	108,041,084	108,041,084	108,030,167